|
|
||||||||

Departments of
*
Surgery and
Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213
We have recently characterized a novel 16-kDa Bax-associated protein. In this study, we investigate the regulation of this proteins expression during in vitro induction of apoptosis in mature splenic B cells. A panel of biochemically distinct apoptotic stimuli induced the dramatic down-modulation of the 16-kDa protein in B cells; this down-modulation was rapid, and did not require DNA fragmentation. Reciprocally, stimuli that induced protection from apoptosis prevented down-modulation of the 16-kDa protein. These regulatory effects were specific, since Bcl-2 and Bax protein levels were not similarly modulated. Stimuli that reduce expression of the 16-kDa protein may therefore act indirectly to increase the proapoptotic activity of Bax, perhaps by altering Bax binding to other cellular proteins.
This article has been cited by other articles:
![]() |
Y. Do, A. Q. Rafi-Janajreh, R. J. Mckallip, P. S. Nagarkatti, and M. Nagarkatti Combined deficiency in CD44 and Fas leads to exacerbation of lymphoproliferative and autoimmune disease Int. Immunol., November 1, 2003; 15(11): 1327 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. He, P. A. Hershberger, and S. A. McCarthy Characterization of a Novel Bax-Associated Protein Expressed in Hemopoietic Tissues and Regulated During Thymocyte Apoptosis J. Immunol., August 1, 1998; 161(3): 1169 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. He, P. A. Hershberger, and S. A. McCarthy Down-Modulation of a Novel Bax-Associated Protein During Apoptosis in Normal Mature B Lymphocytes J. Immunol., August 1, 1998; 161(3): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |